Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Beyer

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Oncoimmunology|November 22, 2012
Interleukin-2 treatment of tumor patients can expand regulatory T cellsMarc Beyer
Seminars in Immunology|March 25, 2015
Epigenetic and transcriptional control of Foxp3+ regulatory T cellsJochen Huehn, Marc Beyer
Immunity|April 14, 2021
ATAC-ing human tissue Treg cellsMaren Köhne, Marc Beyer
Immunity|January 21, 2016
Myelopoiesis Reloaded: Single-Cell Transcriptomics Leads the WayJoachim L Schultze, Marc Beyer
Current Opinion in Biotechnology|July 14, 2017
Genetic engineering as a tool for the generation of mouse models to understand disease phenotypes and gene functionAnn-Kathrin Baumgart, Marc Beyer
Current Pharmaceutical Design|June 13, 2009
Regulatory T cells: major players in the tumor microenvironmentMarc Beyer, Joachim L Schultze
International Immunopharmacology|December 1, 2010
Plasticity of T(reg) cells: is reprogramming of T(reg) cells possible in the presence of FOXP3?Marc Beyer, Joachim L Schultze
Current Oncology Reports|April 2, 2008
Immunoregulatory T cells: role and potential as a target in malignancyMarc Beyer, Joachim L Schultze
Blood|July 25, 2006
Regulatory T cells in cancerMarc Beyer, Joachim L Schultze
Frontiers in Immunology|August 8, 2022
Implications of regulatory T cells in non-lymphoid tissue physiology and pathophysiologyDarya Malko, Tarek Elmzzahi, Marc Beyer
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Oncoimmunology|November 22, 2012
Interleukin-2 treatment of tumor patients can expand regulatory T cellsMarc Beyer
Seminars in Immunology|March 25, 2015
Epigenetic and transcriptional control of Foxp3+ regulatory T cellsJochen Huehn, Marc Beyer
Immunity|April 14, 2021
ATAC-ing human tissue Treg cellsMaren Köhne, Marc Beyer
Immunity|January 21, 2016
Myelopoiesis Reloaded: Single-Cell Transcriptomics Leads the WayJoachim L Schultze, Marc Beyer
Current Opinion in Biotechnology|July 14, 2017
Genetic engineering as a tool for the generation of mouse models to understand disease phenotypes and gene functionAnn-Kathrin Baumgart, Marc Beyer
Current Pharmaceutical Design|June 13, 2009
Regulatory T cells: major players in the tumor microenvironmentMarc Beyer, Joachim L Schultze
International Immunopharmacology|December 1, 2010
Plasticity of T(reg) cells: is reprogramming of T(reg) cells possible in the presence of FOXP3?Marc Beyer, Joachim L Schultze
Current Oncology Reports|April 2, 2008
Immunoregulatory T cells: role and potential as a target in malignancyMarc Beyer, Joachim L Schultze
Blood|July 25, 2006
Regulatory T cells in cancerMarc Beyer, Joachim L Schultze
Frontiers in Immunology|August 8, 2022
Implications of regulatory T cells in non-lymphoid tissue physiology and pathophysiologyDarya Malko, Tarek Elmzzahi, Marc Beyer
Pageof 14